Viromed Medical AG (ETR:VME)
Germany flag Germany · Delayed Price · Currency is EUR
5.75
+0.05 (0.88%)
At close: Oct 6, 2026

Viromed Medical AG Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.225.091.12---
Revenue Growth
2.52%352.27%----
Gross Profit
2.252.29-0.29---
Operating Income
-1.86-0.83-3.5-0.36-0.16-0.01
Net Income
0.340.6-3.09-0.11-0.16-0.01
Earnings Per Share
-0.03-0.15-0.01-0.01-
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.270.360.020.20.150.25
Total Debt
0.070.010.01---
Net Cash (Debt)
0.20.360.010.20.150.25
Net Cash Growth
-43.23%2637.35%-93.35%29.78%-39.04%-
Net Cash Per Share
-0.020.000.010.01-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.12%44.92%-25.60%---
Operating Margin
-35.60%-16.23%-311.14%---
Pretax Margin
-33.69%-13.62%-365.97%---
Profit Margin
6.56%11.88%-274.95%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
354.09127.29----
PS Ratio
23.2215.1344.65---